ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Astellas Pharma Global Development, Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
pembrolizumabsafety
locally advanced or metastatic solid tumors, asp388b, safety, tolerability, pembrolizumab, carboplatin, 5-fluorouracil (5-fu), oxaliplatin, head and neck squamous cell carcinoma (hnscc), esophageal squamous cell carcinoma (escc), metastatic castration-resistant prostate cancer(mcrpc), squamous non-small cell lung cancer (sqnsclc)
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 806826
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.